Dual HER2 Blockade Promising in HER2-Positive Metastatic CRC
Dual HER2 blockade with trastuzumab and lapatinib yielded good response rates in HER2-amplified, RAS wild type, treatment-refractory metastatic colorectal cancer patients, according to results of the HERACLES study.
Vaccines to Prevent High-Grade Glioma
This video examines current research on the use of vaccines in low-grade glioma for the prevention of high-grade disease.
Biomarkers Could Predict Bladder Cancer Progression
This video examines a study that used liquid biopsies to monitor disease progression in patients with bladder cancer.
Immunotherapeutic Agents in Breast Cancer
This video reviews the latest trials and research on immunotherapeutic agents being tested in breast cancer.
CheckMate 067 Shows OS Improved With Nivolumab/Ipilimumab in Melanoma
A nivolumab/ipilimumab combination significantly improved overall survival for advanced melanoma patients.
MicroRNA Signature Predicted Breast Cancer Survival, Bone Metastasis
This video highlights a novel scoring system using microRNA signatures that predicted poor overall survival and bone metastasis in patients with luminal A breast cancer.
Marker May Predict Immunotherapy Benefit in High-Risk Neuroblastoma
This video examines how a specific combination of KIR/KIR-ligand genotypes in high-risk neuroblastoma patients may be predictive of outcomes when adding dinutuximab to isotretinoin.
By clicking Accept, you agree to become a member of the UBM Medica Community.